Highlights 2014

• Net profit increased by 45% and amounted to USD 59 million or 12% of sales, compared to USD 41 million or 9% of sales in 2013.

• Sales amounted to USD 509 million compared to USD 436 million in 2013, corresponding to 18% growth and 5% organic growth, both measured in local currency.

• Bracing and supports sales growth in 2014 was 18% and 1% organic, both measured in local currency.

• Prosthetics sales growth in 2014 was 17% and 11% organic, both measured in local currency.

• Gross profit amounted to USD 323 million and 63% of sales, compared to USD 270 million and 62% of sales in 2013.

• EBITDA increased by 38% and amounted to USD 104 million or 20% of sales, compared to USD 75 million or 17% of sales in 2013. EBITDA margin adjusted for one-time expenses was 18% of sales in 2013.

• Cash generated by operations amounted to USD 98 million or 19% of sales, compared to USD 73 million or 17% of sales in 2013.

• Two small acquisitions were completed in the Asia-Pacific segment, APAC (previously referred to as Asia segment) during the year, which further strengthened the sales platform.

• The Board of Directors will propose to the Annual General Meeting in 2015 that the Company pays a cash dividend of DKK 0.12 per share for 2014, an increase of 20% from 2013 and equivalent to 14% of net earnings in 2014.

• The Board of Directors will also propose to the Annual General Meeting to reduce the share capital by cancelling 7,456,755 of the Company's own shares.